HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jacques Touchon Selected Research

dimethylaminoethanol pyroglutamate

1/2012Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jacques Touchon Research Topics

Disease

35Alzheimer Disease (Alzheimer's Disease)
02/2022 - 02/2002
10Dementia (Dementias)
02/2022 - 02/2002
9Cognitive Dysfunction
02/2022 - 12/2003
3Narcolepsy
03/2010 - 12/2004
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016 - 01/2006
2Atrophy
09/2015 - 01/2013
2Cataplexy
03/2010 - 12/2004
2Lewy Body Disease (Lewy Body Dementia)
01/2006 - 08/2005
2Disease Progression
12/2003 - 02/2002
1Hypertension (High Blood Pressure)
11/2020
1Frailty
11/2020
1Weight Loss (Weight Reduction)
11/2020
1Atrial Fibrillation
11/2020
1Obesity
11/2020
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2020
1Orthostatic Hypotension (Postural Hypotension)
11/2020
1Craniocerebral Trauma (Head Injury)
11/2020
1Neuroinflammatory Diseases
01/2018
1Prodromal Symptoms
12/2016
1Cerebral Cortical Thinning
12/2016
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
09/2015
1Frontotemporal Dementia (Semantic Dementia)
01/2011
1Nervous System Diseases (Neurological Disorders)
10/2008
1Restless Legs Syndrome (Restless Legs)
03/2007
1Parkinson Disease (Parkinson's Disease)
09/2006
1Nausea
03/2006
1Vomiting
03/2006
1Vitamin E Deficiency
01/2006
1Sleep Initiation and Maintenance Disorders (Insomnia)
12/2004

Drug/Important Bio-Agent (IBA)

22Biomarkers (Surrogate Marker)IBA
02/2022 - 02/2002
6Amyloid (Amyloid Fibrils)IBA
01/2018 - 01/2012
6Pharmaceutical PreparationsIBA
05/2016 - 12/2004
6Cholinesterase Inhibitors (Anticholinesterases)IBA
11/2014 - 10/2003
5Donepezil (Aricept)FDA LinkGeneric
12/2016 - 08/2005
5Rivastigmine (Exelon)FDA LinkGeneric
09/2006 - 10/2003
4Amyloid beta-PeptidesIBA
02/2022 - 02/2002
4Peptides (Polypeptides)IBA
01/2018 - 02/2002
3Biological ProductsIBA
01/2014 - 10/2007
2tau Proteins (tau Protein)IBA
01/2012 - 02/2002
2OrexinsIBA
03/2010 - 12/2004
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
11/2020
1Neuroprotective AgentsIBA
01/2018
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
05/2017
1Memantine (Namenda)FDA Link
11/2014
1Indicators and Reagents (Reagents)IBA
07/2013
1Apolipoproteins E (ApoE)IBA
01/2013
1Ginkgo biloba extract (Rokan)IBA
10/2012
1dimethylaminoethanol pyroglutamateIBA
01/2012
1pigment epithelium-derived factorIBA
03/2011
1HaptoglobinsIBA
03/2011
1Glucose (Dextrose)FDA LinkGeneric
03/2010
1HLA-DQB1 antigen (HLA DQB1)IBA
03/2010
1Blood Proteins (Serum Proteins)IBA
10/2008
1ProteomeIBA
10/2008
1Dopamine (Intropin)FDA LinkGeneric
03/2007
1Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
03/2007
1Cholinergic Agents (Cholinergics)IBA
09/2006
1Cholinergic Antagonists (Anticholinergics)IBA
02/2006
1Vitamin EFDA LinkGeneric
01/2006
1AntioxidantsIBA
01/2006
1Apolipoprotein E4IBA
01/2006
1EnzymesIBA
08/2005
1ButyrylcholinesteraseIBA
08/2005
1Intravenous Immunoglobulins (IVIG)FDA Link
12/2004
1Hypnotics and Sedatives (Sedatives)IBA
12/2004
1Biological FactorsIBA
12/2003
1Progestins (Progestagens)IBA
10/2003
1Amino AcidsFDA Link
02/2002

Therapy/Procedure

7Therapeutics
12/2016 - 12/2003
3Cognitive Training
05/2017 - 03/2009
2Activities of Daily Living (ADL)
12/2011 - 10/2003
1Low-Level Light Therapy (LLLT)
01/2018
1Institutionalization (Institutionalized Persons)
05/2016
1Home Nursing (Nursing, Home)
11/2014
1Music Therapy
09/2013
1Secondary Prevention
07/2013
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
10/2003